Todd Cushman

Prior to joining Neuronetics, Mr. Cushman was a founding member of Bioness, Inc., a medical technology company specializing in neuro rehabilitation and implantable products for pain management. At Bioness, he held various commercial and operational roles from 2004 – 2012, and served as President and CEO from 2013 until the company was acquired by Bioventus, Inc., in March of 2021. During his tenure at Bioness, Mr. Cushman work closely with the Chairman of the Board, renowned medical entrepreneur Alfred Mann, to develop Bioness and acquire, sell and license medical device IP, technologies and companies in the Mann Group. He brings with him extensive experience in executive leadership, product development, global operations, mergers and acquisitions.

Mr. Cushman began his career in medical devices at American Hospital Supply Corporation (now Baxter, Inc.) in sales and marketing. In 1984, he founded Acumed, Inc., a medical manufacturing and distribution company which was acquired by Medtronic, Inc. in 1999. From 1999 – 2004, Mr. Cushman served as Group Director for Medtronic’s Neurosurgical, Spinal Products and Image-guided Surgery Divisions.

Mr. Cushman has a BA from Brown University and an MBA from the Marshall School of Business at the University of Southern California. Mr. Cushman serves on the Boards of Directors for Voiceitt and the Alfred Mann Institute at the Technion – Israel Institute of Technology.